Istiratumab
Istiratumab (M-6495) is bispecific monoclonal antibody targeting IGF-1R and ErbB3. Istiratumab induces IGF-1R and ErbB3 receptor degradation through the proteasome pathway Istiratumab can be used for research of cancers[1][2][3].
Product Specifications
Product Name Alternative
MM 141; MM-005
UNSPSC
12352203
Target
EGFR; IGF-1R
Type
Inhibitory Antibodies
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/istiratumab.html
Purity
98.45
Solubility
10 mM in DMSO
Smiles
[Istiratumab]
Molecular Weight
(199.63 kDa)
References & Citations
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-P99672/Istiratumab-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-P99672/Istiratumab-SDS-MedChemExpress.pdf
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
CAS Number
[1509928-04-4]
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items